Portfolio Companies 2026 for Frazier Life Sciences: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Frazier Life Sciences accounts for 21 tracked companies with verified cap-table data, 21 of which disclose round sizes totalling $4B. The median disclosed raise is $180M, and the largest is Angitia Biopharmaceuticals at $406M, ahead of Alentis Therapeutics ($366M) and Axon Neurosciences ($340M).
The names that recur most often on these portfolio cap tables are Frazier Life Sciences (21 companies), OrbiMed (6 companies), RA Capital Management (6 companies), Deep Track Capital (4 companies), Janus Henderson Investors (3 companies), Longitude Capital (3 companies). By latest disclosed round, the market skews Series A (8), Series B (6), Series C (3), Series D (2).
Companies tracked: 21
Disclosed funding total: $4B across 21 companies
Median disclosed raise: $180M
Largest raise: Angitia Biopharmaceuticals — $406M
Stage mix: Series A 8 · Series B 6 · Series C 3 · Series D 2
